首页 | 本学科首页   官方微博 | 高级检索  
     


IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro
Authors:Brand Stephan  Dambacher Julia  Beigel Florian  Zitzmann Kathrin  Heeg Malte H J  Weiss Thomas S  Prüfer Thomas  Olszak Torsten  Steib Christian J  Storr Martin  Göke Burkhard  Diepolder Helmut  Bilzer Manfred  Thasler Wolfgang E  Auernhammer Christoph J
Affiliation:Department of Medicine II, University-Hospital Munich-Grosshadern and University of Munich, Marchioninistrasse 15, 81377 Munich, Germany. stephan.brand@med.uni-muenchen.de
Abstract:The IL-10-like cytokine IL-22 is produced by activated T cells. In this study, we analyzed the role of this cytokine system in hepatic cells. Expression studies were performed by RT-PCR and quantitative PCR. Signal transduction was analyzed by Western blot experiments and ELISA. Cell proliferation was measured by MTS and [(3)H]thymidine incorporation assays. Hepatocyte regeneration was studied in in vitro restitution assays. Binding of IL-22 to its receptor complex expressed on human hepatic cells and primary human hepatocytes resulted in the activation of MAPKs, Akt, and STAT proteins. IL-22 stimulated cell proliferation and migration, which were both significantly inhibited by the phosphatidylinositol 3-kinase inhibitor wortmannin. IL-22 increased the mRNA expression of suppressor of cytokine signaling (SOCS)-3 and the proinflammatory cytokines IL-6, IL-8, and TNF-alpha. SOCS-1/3 overexpression abrogated IL-22-induced STAT activation and decreased IL-22-mediated liver cell regeneration. Hepatic IL-22 mRNA expression was detectable in different forms of human hepatitis, and hepatic IL-22 mRNA levels were increased in murine T cell-mediated hepatitis in vivo following cytomegalovirus infection, whereas no significant differences were seen in an in vivo model of ischemia-reperfusion injury. In conclusion, IL-22 promotes liver cell regeneration by increasing hepatic cell proliferation and hepatocyte migration through the activation of Akt and STAT signaling, which is abrogated by SOCS-1/3 overexpression.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号